REGISTRATION DOCUMENT AND FINANCIAL REPORT - Iliad

21. ADDITIONAL INFORMATION
21.1 SHARE CAPITAL
The table below sets out the main characteristics of the stock options granted by the Company which were
outstanding at March 31, 2008.
Date of Shareholders’ Meeting ............................................................
First stock option plan
December 12, 2003
Date of Board meeting ............................................................... January 20, 2004
Total number of options granted by the Board of Directors ............................ 485,769
o/w to members of the Board of Directors ............................................. 0
Total number of beneficiaries ......................................................... 22
Exercise price per share (in € ) ........................................................ 16.30
Exercise date of the options ........................................................... January 20, 2008
Expiration date of the options ......................................................... January 19, 2014
Number of options exercised ......................................................... 159,800
Number of options forfeited .......................................................... 76,335
Total number of exercisable options .................................................. 249,634
New number of beneficiaries ......................................................... 18
Total number of new shares to be issued .............................................. 249,634
Maximum dilutive impact of the options ..............................................
Second stock option plan
0.46%
Date of Board meeting ............................................................... December 20, 2005
Total number of options granted by the Board of Directors ............................ 541,51543 o/w to members of the Board of Directors ............................................. 243,684
Total number of beneficiaries ......................................................... 84
Exercise price per share (in € ) ........................................................ 48.44
Exercise date of the options ........................................................... December 20, 2009
December 20, 2010
Expiration date of the options ......................................................... December 19, 2015
Number of options exercised ......................................................... 0
Number of options forfeited .......................................................... 105,06244 Total number of exercisable options .................................................. 0
New number of beneficiaries ......................................................... 69
Total number of new shares to be issued .............................................. 436,453
Maximum dilutive impact of the options ..............................................
Third stock option plan
0.81%
Date of Board meeting ............................................................... June 14, 2007
Total number of options granted by the Board of Directors ............................ 162,455
o/w to members of the Board of Directors ............................................. 162,455
Total number of beneficiaries ......................................................... 1
Exercise price per share (in € ) ........................................................ 74.62
Exercise date of the options ........................................................... June 14, 2012
Expiration date of the options ......................................................... June 13, 2017
Number of options exercised ......................................................... 0
Number of options forfeited .......................................................... 0
Total number of exercisable options .................................................. 0
Total number of new shares to be issued .............................................. 162,455
Maximum dilutive impact of outstanding options .....................................
Fourth stock option plan
0.30%
Date of Board meeting ............................................................... August 30, 2007
Total number of options granted by the Board of Directors ............................ 162,455
o/w to members of the Board of Directors ............................................. 0
Total number of beneficiaries ......................................................... 1
Exercise price per share (in € ) ........................................................ 68.17
Exercise date of the options ........................................................... August 30, 2012
Expiration date of the options ......................................................... August 29, 2017
Number of options exercised ......................................................... 0
Number of options forfeited .......................................................... 0
Total number of exercisable options .................................................. 0
Total number of new shares to be issued .............................................. 162,455
Maximum dilutive impact of outstanding options ..................................... 0.30%
43 o/w half exercisable at each year-end
44 o/w 81,228 options belong to former employee directors
Iliad – Registration Document 2007 - 191